Table 5.
Results of the multivariate regression analysis
| 85 years old and over | 75 to 84 years old | ||||
|---|---|---|---|---|---|
| Associated factor | OR (95% CI) | p | Associated factor | OR (95% CI) | p |
| Beers | Beers | ||||
| Number of medicines | Number of medicines | ||||
| ● 10 or more | 5.7 (1.8-17.9) | 0.003 | ● 5 - 9 | 6.3 (1.1-34.4) | 0.035 |
| ● 10 or more | 11.0 (2.0- 59.7) | 0.006 | |||
| Female gender | 1.9 (1.1-3.1) | 0.014 | |||
| START-listed PPO | 1.8 (1.0-2.9) | 0.027 | |||
| STOPP | STOPP | ||||
| Number of medicies | Number of medicines | ||||
| ● 5 - 9 | 5.7 (1.8-17.8) | 0.003 | ● 10 or more | 5.1 (1.5-16.8) | 0.007 |
| ● 10 or more | 13.4 (4.0-44.0) | <0.001 | ACOVE-3-listed PPO | 2.2 (1.2-3.6) | 0.004 |
| Severe dependence in | |||||
| ADL | 5.0 (1.1-22.1) | 0.031 | |||
| Multimorbidity | 0.5 (0.2-0.9) | 0.045 | |||
| START | START | ||||
| Non-community dwelling | 2.3 (1.0-5.0) | 0.030 | Multimorbidity | 1.9 (1.0-3.2) | 0.027 |
| Multimorbidity | 1.8 (1.0-3.1) | 0.040 | |||
| ACOVE-3 | ACOVE-3 | ||||
| STOPP-listed PIM | 2.5 (1.4-4.3) | 0.001 | STOPP-listed PIM | 2.2 (1.2-3.8) | 0.004 |
Only the statistically significant risk factors associated to PIM and PPO tools are presented.